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Florian Beissner ,5 Henrik Szöke ,6 Stefanie Joos ,7 and Ursula Wolf 8
1ARCIM Institute (Academic Research in Complementary and Integrative Medicine), Im Haberschlai 7,
70794 Filderstadt, Germany
2Department of Neonatology, University Hospital Tuebingen, Calwerstraße 7, 72076 Tuebingen, Germany
3Department of Pediatrics, Filderklinik, Im Haberschlai 7, 70794 Filderstadt, Germany
4Institute of Precision Medicine, University Furtwangen, Jakob-Kienzle-Straße 17, 78054 Villingen-Schwenningen, Germany
5Insula Institute for Integrative 8erapy Research, Brabeckstraße 177E, 30539 Hannover, Germany
6Department of Integrative Medicine, University of Pécs, Vörösmarty Utca 3, 7623 Pécs, Hungary
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Objectives. To examine the effects of warm footbaths with thermogenic medicinal powders on vitality and heart rate variability in
healthy adults. Intervention and Outcome. Seventeen healthy young adults (22.1± 2.4 years, 11 females) received three footbaths
(WA: warm water only; GI: warm water and ginger; MU: warm water and mustard) in randomized order with a crossover design.
We assessed vitality with the Basler Befindlichkeit questionnaire (BBS) and heart rate variability (HRV) before (t0), immediately
after (t1), and 10minutes following footbaths (t2).'e primary outcomemeasure was self-reported vitality, measured via the BBS,
at t1. Results.'e primary outcomemeasure, self-reported vitality, was higher after GI and tended to be higher afterMU compared
to WA with medium effect sizes (GI vs. WA, mean difference −2.47 (95% CI −5.28 to 0.34), padj � 0.048, dadj � 0.74), MU vs. WA,
−2.35 (−5.32 to 0.61), padj � 0.30, dadj � 0.50). At t2, the standard deviation of beat-to-beat intervals (SDNN) of HRV increased,
and the stress index tended to decrease after all three footbath conditions with small to medium effect sizes (0.42–0.66).
Conclusion. 'ere is preliminary evidence that footbaths with thermogenic agents GI and MU may increase self-reported vitality
during a short-time period with a more pronounced effect with GI. After a short follow-up, all three conditions tended to shift the
autonomic balance towards relaxation. Future research should investigate these effects in clinical samples with a larger, more
diverse sample size.
1. Introduction
Fatigue and reduced vitality are frequent symptoms in many
disorders [1, 2] such as cancer, depression, or multiple
sclerosis [1, 3, 4] and are also common complaints in
otherwise healthy individuals [1, 4]. Self-reported vitality is
defined as a positive sense of energy and aliveness [5, 6] and
is influenced by both somatic and psychological factors [5].
Vitality is a marker of health status [5], which is associated
with beneficial immune and antiviral responses [6] and
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reduced risk of cardiovascular disease [7]. Lower vitality and
fatigue can origin from being overweight [4] or from
physical or mental stress [1, 3]. Hancock (1995) described the
problem of fatigue in daily life as follows: “We’re fried by
work, frazzled by the lack of time. [. . .] No wonder one-
quarter of us say we’re exhausted” [1]. Direct consequences
of acute stress are changes in heart rate variability (HRV) [8],
a sympathetically mediated vasoconstriction, which in turn
is accompanied by a drop in skin temperature [9], myo-
cardial ischemia, and an increased risk for cardiovascular
events [10]. Beyond that, low vitality is associated with a
higher risk for cancer, cardiovascular disease, and an ele-
vated mortality risk [11]. 'us, reducing perceived stress is a
desirable aim in the treatment of diseases and also for
healthy individuals [12].
Warm footbaths could be beneficial for increasing self-
reported vitality as they induce relaxing effects [13–18] and
increase comfort and the sense of well-being [14]. Associ-
ations have been reported between physical health, en-
dogenous warmth, and well-being [19]. 'e application of
footbaths has effects not only on distal skin temperatures,
but also on perceived body warmth [20, 21] and, thus, could
meaningfully impact the sense of vitality. However, the
effects of footbaths on autonomic function are inconsistent
and conflicting [13, 14, 16, 17, 22]. 'ese mixed findings
indicate that potential effects may depend on the experi-
mental conditions and settings [16]. Of note, the majority of
the available research focuses on footbaths with warm water
only (WA). Further benefits may derive from the addition of
thermogenic substances, such as ginger (Zingiber officinale,
GI) and mustard (Sinapis nigra, MU), given that their active
ingredients are able to penetrate skin when externally ap-
plied [20, 23–25]. Nonetheless, the effect of these substances
on self-reported vitality remains unclear when added to
warm footbaths.
'is study was part of a larger initiative that aimed to
examine the psychophysiological effects of footbaths with GI
and MU. Previous research focused on short-term changes
in warmth perception and skin temperature [20], as well as
on the specific profiles of action of both substances during
the footbaths (not yet published). 'e purpose of this
analysis was to investigate the effects of footbaths with GI,
MU, or WA on the self-reported vitality, mental state, and
HRV, which adds new scientific contribution to the existing
literature.
2. Methods
2.1. StudyDesign. 'is study followed a blinded randomized
vehicle-controlled clinical trial with a crossover design.
Participants received all three conditions in a random se-
quence with a washout period of at least 2 days between the
different footbaths. 'e study was conducted at the ARCIM
Institute, Germany, from October to December 2013. 'e
design was reviewed and approved by the ethics committee
of the University of Tuebingen and was recorded at the
German Clinical Trials Register (DRKS) (DRKS00005350).
All participants provided written informed consent before
enrollment.
2.2. StudyPopulation. To recruit participants, we distributed
flyers and posted announcements at the school of nursing at
a German hospital. Eligible participants were adults (all
gender), with ages being 18–30 years old. Exclusion criteria
included infectious diseases (with more than 38°C core body
temperature), skin injuries in the lower legs or feet, cardiac
arrhythmias, pregnancy, hypersensitivity to GI or MU
products, self-reported use of medication that could influ-
ence study’s outcome measures (vasoactive substances or
medication with influence on heart rate variability such as
sympathomimetic/sympatholytic drugs, phosphodiesterase
inhibitors, or tricyclic antidepressants [26]), bronchial
asthma, and insufficient knowledge of the German language.
Participants were asked to provide information about their
sex, age, height, and weight in order to determine their body-
mass-index (BMI). Participants were also asked to refrain
from consuming coffee or nicotine within three hours before
each of the three footbath interventions.
2.3. Study Interventions. We began each footbath inter-
vention with a brief verbal introduction (2min). For reasons
of observation and data collection, participants were pro-
vided with hospital gowns to leave the feet and lower legs
uncovered. We instructed participants to sit quietly for ten
minutes in order to achieve a relaxed and stable starting
point prior to data collection. Following the relaxation
period, participants received the footbath containing either
WA, MU, or GI. We instructed them to keep their feet
immersed as long as they felt comfortable. However, to
minimize the potential for harm (e.g., skin irritation or
burning), we did not permit participants to exceed a
maximum limit of 20 minutes. We prepared all footbaths
with 12 liters of water heated to 40.0± 0.1°C, placed within
plastic tubs (water depth: 15 cm). When evaluating MU or
GI, we added eighty grams of prepared powder (Caesar &
Loretz GmbH, Hilden, Germany) leading to 6.67 g/l. Both
powders were produced according to Good Manufacturing
Practice (GMP) in compliance with the German Drug Law
(AMG) and the German Good Manufacturing Regulation
(Arzneimittel-und Wirkstoffherstellungsverordnung,
AMWHV). After the footbaths, participants remained
seated quietly for ten minutes (recovery period). We
monitored the duration of footbath immersion, water and
room temperature, and humidity at each session. In order to
account for the circadian rhythmicity of the autonomic
nervous system [27] and to achieve standardization, we
conducted all footbath interventions and associated mea-
surements between 1:30 and 6:30 pm. 'e mean washout
period between successive footbaths was 7.7± 6.6 days
(Min� 2, Max� 24), and the mean total time to complete all
three footbath conditions was 15.4± 7.2 days (Min� 7,
Max� 27).
2.4. Study Outcome Measures. 'e Basler Befindlichkeit
questionnaire (BBS) was used to assess changes in self-re-
ported feelings of well-being and actual status of mood. 'e
BBS is a validated 16-item questionnaire (Cronbach’s alpha
0.83≥ α≥ 0.91) [28] that requires approximately 5 minutes
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for completion. Items are rated on a seven-point Likert scale
(ranging from 1� low level of activation to 7� high level of
activation) and summed according to the subscales vitality,
inner balance, vigilance, and social extroversion (scale 4–28),
as well as calculation of a total sum score (scale 16–112). 'e
BBS was administered before intervention (baseline or t0),
directly after immersion (postimmersion or t1), and 10
minutes following the footbath (follow-up or t2). 'e pri-
mary outcome measure was the BBS subscale vitality at t1.
Secondary outcomemeasures were the BBS subscales vitality
(at t2), inner balance, vigilance, social extroversion, and the
total sum score of all items (at t1 and t2).
Other outcome measures included cardiorespiratory
parameters measured with the SRMCardioScout Multi ECG
System (Innovative Medical Solutions, Stuttgart, Germany)
and analyzed with the HRV Scanner BioSign software
(BioSign GmbH, Ottenhofen, Germany). 'e ECG was
recorded throughout the entire intervention period (from t0
to t2). For analysis, the last 6 minutes of the baseline re-
laxation period, the footbath immersion, and the recovery
period were taken, and of these, the last minute was dis-
carded to ensure recoding quality and adequate duration,
which resulted in five-minute segments per measurement
period (t0, t1, and t2).'ese segments underwent automated
t-wave detection followed by analysis of the R-R-interval
time course in both time domain and frequency domain. We
assessed the following time domain measures: standard
deviation of beat-to-beat intervals (SDNN, ms) and root
mean square of successive differences (RMSSD, ms). 'e
SDNN is amarker of overall cardiac heartrate variability [29]
and displays the aggregated modulation of the sympathetic
and parasympathetic activities [30], while the RMSSD
represents parasympathetic activity [29]. With respect to
frequency domain measures, we calculated the ratio between
low frequency (LF, 0.04–0.15Hz) and high frequency (HF,
0.15–0.40Hz), a parameter for assessing the sympathovagal
balance [31]. From the HRV scanner calculations, we further
assessed the respiratory rate (1/min) and the stress index as
calculated by Baevsky [32].
2.5. Sample Size. We were not able to identify any published
studies examining the effects of footbaths with MU or GI on
the mental state or HRV. 'us, parameters needed to es-
timate sample size were unavailable. We selected a conve-
nience sample of 18 participants as initial evaluation.
2.6. Randomization. Randomization was carried out in the
presence of the study nurse at the first of the three ap-
pointments. Participants were randomly assigned to receive
the three intervention conditions in different sequences,
stratified by gender. Based on the study design, six different
sequences were possible and were encoded by the group
designations a-f (a�MU−WA−GI, b�MU−GI−WA,
c�WA−GI−MU, d�WA−MU−GI, e�GI−MU−WA,
and f�GI−WA−MU). We prepared three copies of each
group sequence, with each being enclosed in a sealed,
nontransparent envelope. Participants drew one of these
opaque envelopes and the study nurse documented the
group/sequence assignment. Participants were provided
with study identification numbers for purposes of confi-
dentially tracking progress over time.
2.7. Blinding. Participants were kept unaware to the allo-
cated footbath sequence. To avoid unblinding and to prevent
potentially biased responses because of any visual cues of the
substances being used, we covered the footbaths with towels
during the intervention. We further applied a room spray
containing essential oils between t0 and t1 in order to di-
minish any olfactory hints of the ginger or mustard. Before
the intervention, we verified blinding by asking each par-
ticipant “what kind of substance do you smell?” (response
options: MU, GI, eucalyptus, lavender, citrus, and pepper-
mint) with multiple answers being permitted. After each
intervention, we asked participants “which condition did
you receive today?” and provided the response options MU,
GI, or WA.
2.8. Statistical Analysis. All analyses were performed with R
(R Core Team) [33] running in RStudio (RStudio Team)
[34]. Multiple imputation by chained equations was used to
replace missing values (R package: mice [35]). We set the
significance level for analysis at α� 0.05 (two-tailed). We
first applied the procedure proposed by Wellek and Blettner
[36] in order to assess potential asymmetrical sequence
effects due to the interaction of treatment and carryover
effects. We therefore calculated the total (sum) of all three
periods of the initial values (t0) of the primary outcome
measure per subject. A nonsignificant finding in a subse-
quent one-factorial analysis of variance (ANOVA) with
randomization group as the factor would allow us to pool the
groups together for the analysis of intervention effects.
Baseline demographics were reported descriptively. We
analyzed the primary outcome measure (BBS vitality at t1)
using a linear mixed effects model (R package: lme4 [37])
allowing for the footbath condition (WA, MU, and GI) as
fixed effect and the subjects as random effect. 'e baseline
measurement of the primary outcome measure (t0) was
fitted as covariate. In the process of model selection, we
calculated 95% confidence intervals (CI), the Akaike in-
formation criterion (AIC), and the Bayesian information
criterion (BIC) and conducted a likelihood ratio statistic to
decide whether the baseline measurements of the primary
outcome measure (t0) or the footbath immersion duration
should be considered as covariates. For the final model, we
applied the method of Kenward and Roger for test statistics’
approximation [38]. Post hoc comparisons of a significant
main effect were based on the lmerTest package [39] with p
values being adjusted by using a Bonferroni correction. 'e
calculation of Cohen’s d effect sizes was based on the co-
variate adjusted means and standard deviations (dadj). For all
outcome measures, we calculated mean differences between
the footbath conditions at t0, t1 and t2 as well as mean
differences between t0− t1 and t0− t2 within each footbath
condition with 95%-CI and Cohen’s effect sizes (R package:
effsize [40]).We analyzed baseline comparisons of the room/
water temperature and humidity with one-factorial
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ANOVAs with condition as the factor. To test differences in
the immersion times between the footbath conditions, we
executed a one-factorial mixed ANOVA with condition as
the fixed effect and subjects as the random effect.'e success
of blinding was verified using the
Cochran–Mantel–Haenszel chi-squared statistics taking the
total number of olfactory perceptions into account as
confounder. Data was cross-checked to assure it conformed
to a normal distribution.
3. Results
3.1. Study Population. Twenty-four individuals were
assessed for eligibility, of whom three (12%) did not meet the
inclusion criteria (one was older than 30 years; two reported
skin problems) and three (12%) decided not to participate.
We randomly assigned the remaining 18 participants but
subsequently excluded one (6%) from analysis upon dis-
covering she had bronchial asthma requiring regular
medication (Figure 1). 'e final sample (n� 17) consisted of
eleven women (65%) and six men (35%) between 19 and 28
years of age (m� 22.1± 2.5) with an average BMI of
22.8± 3.7 kg/m2. Baseline data (Table 1) were similar be-
tween the groups.
3.2. Baseline Conditions. Mean starting conditions were a
room temperature of 23.2± 0.8°C, a humidity index of
39.6± 7.6%, and a water temperature of 40.0 ± 0.1°C. For
these parameters, no significant differences were found
between the footbath conditions (room temperature: F (2,
48) � 2.78, p � 0.07; humidity: F (2, 48) � 0.49, p � 0.62;
water temperature: F (2, 48) � 0.86, p � 0.43). However, we
found a significant difference with respect to participants’
voluntary footbath immersion duration (F(2, 32) � 32.10,
p< 0.001; MU: m � 11.47 ± 5.06 minutes, GI:
m � 16.94 ± 3.54 minutes, WA: m � 20.00 ± 0.00 minutes).
A Bonferroni-adjusted post hoc analysis revealed signifi-
cant differences between all conditions and large effect sizes
(WA vs. MU: p< 0.001, d � 2.38; WA vs. GI: p< 0.01,
d � 0.84; MU vs. GI: p< 0.001, d � 1.06). 'ree participants
reported coffee intake within three hours before the
footbath intervention (1 in each condition). Based on the
potential interaction between caffeine, self-reported vital-
ity, mental state, and HRV parameters [41–48], these
measurements were excluded from analysis and replaced
with missing imputation. Approximately 6% of BBS and
12% of HRV data were missing and were imputed via
MICE.
3.3. Analysis of Possible Carryover Effects. We detected no
significant difference between the total sum for the primary
outcome measure (BBS vitality) of the six different sequence
groups at t0 (F (5, 11)� 0.57, p � 0.72). 'us, we assumed
that possible carryover effects were negligible. Randomi-
zation groups were pooled together with regard to the in-
tervention received for the following main analysis (WA vs.
MU vs. GI) (n� 17).
3.4. Model Selection. In order to determine the optimal
mixed effects analysis, we compared three models (wherein
condition served as fixed effect, and subjects as the random
effect): model A, without covariates; model B, with baseline
measurements of BBS vitality (t0) as covariate; and model C,
with immersion duration as the only covariate. Model de-
cision was based on a CI calculation (model B: baseline
measurement: 0.35; 0.78, model C: immersion time: −0.21;
0.38) and on a model comparison considering the AIC
(modelA: 287.18, model B: 266.08, modelC: 288.85), the BIC
(modelA: 296.84, model B: 277.67, model C: 300.44), and the
likelihood ratio statistics (model B: (1)� 23.10, p< 0.01,
model C: X2diff (0)� 0.00, p � 1.00). Based on these results,
we decided to apply model B (with baseline BBS vitality as
covariate) for analyzing the primary outcome measure.
3.5. Outcomes and Estimations
3.5.1. Primary Outcome: BBS Vitality at t1. Vitality differed
significantly between the footbath conditions at t1 (F (2,
31)� 3.38, p � 0.047). Post hoc analyses revealed that the
covariate adjusted mean after GI (Madj � 20.65, SDadj � 3.21)
was significantly higher than that of WA only (Madj � 18.29,
SDadj � 3.21) (t (30)� −2.55, padj � 0.048, dadj � 0.74). No
significant differences and smaller effect sizes were found for
the post hoc comparisons between MX2diffU (Madj � 19.88,
SDadj � 3.23) and WA (t (31)� 1.70, padj � 0.30, dadj � 0.50)
and between MU and GI (t (31)� −0.83, padj � 1.00,
dadj � 0.24). 'e descriptive analysis pointed to a higher
self-reported vitality after GI and MU compared to WA
(Figure 2), which can be seen as a trend in the between-
differences (medium effect sizes for the comparisons between
WA and MU, as well as between WA and GI at t1, Table 2)
and in the increase of the within-differences (significant in-
creases between t0 and t1 for GI and MU, Table 3).
3.5.2. Secondary Outcomes: BBS. 'e descriptive analysis
yielded no significant differences between (Table 2) or within
(Table 3) the footbath conditions over time. However, the
effect sizes pointed to the trends of a sustained increase of
self-reported vitality (Table 2, WA vs. GI: d� 0.35; Table 3,
GI, t2 vs. t1: d� 0.57) and of higher increases of the total sum
score (Table 3, GI, t1 vs. t0: d� 0.43, t2 vs. t0: d� 0.30) after
GI.
3.5.3. Secondary Outcomes: HRV. With respect to the mean
between-substance differences, the footbaths did not sig-
nificantly differ as a function of time (Table 4). Moreover, no
differences were seen for the within-substance differences
between t0 and t1 (Table 3). However, with respect to the
changes between t0 and t2, the SDNN increased significantly
in all footbath conditions with higher effect sizes for GI
(d� 0.61) and MU (d� 0.57). Regarding the stress index, a
significant reduction occurred for MU and WA between t0
and t2 (both d� 0.66), while for GI, a tendential reduction
was seen (d� 0.42). For MU and WA, the trend of these
changes was already apparent at t1. In contrast, directly after
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GI, the tendencies of an initial decline in the SDNN and an
unchanged stress index were seen (Table 3). 'e changes of
the RMSSD, LF/HF-Ratio and the respiration rate were less
clear. 'e RMSSD tended to increase between t0 and t2 after
all footbath conditions with a significant effect for WA
(despite a small effect size) (Table 3). 'e between-substance
differences pointed to a lower LF/HF-Ratio after GI com-
pared to WA at t1 and t2 (0.56≥ d≥ 0.66) (Table 4). 'is
might be related to an unchanged ratio after WA (d� 0.01)
and to a slightly decreased ratio after GI (d� 0.33) (Table 3).
'e within-substance differences indicated no homogenous
changes of the respiration rate (Table 3). 'e trend of a
higher respiration rate after GI and WA compared to MU
might, therefore, be attributed to the differing baseline
values (Table 4).
3.6. Success of Blinding. A total of 51 footbaths were ad-
ministered as each of the 17 participants received all three
conditions. At t0, the correct footbath thermogenic ingre-
dient was named in nine cases (18%) (MU: n� 5, GI: n� 4).
'e substances most frequently mentioned as olfactory
perceptions were citrus (n� 31) and eucalyptus (n� 16). We
found no significant association between GI and GI olfactory
perceptions (X2 (1)� 1.06, p � 0.30) or between MU and
MU olfactory perceptions (X2 (1)� 2.98, p � 0.08), so that
Assessed for eligibility (n = 24)
Randomized (n = 18)
Group a (n = 3)
Group a (n = 3)
Group a (n = 3)
Group b (n = 3)
Group b (n = 3)
Group b (n = 3)
Group c (n = 3)
Group c (n = 3)
Group c (n = 3)
Group d (n = 3)
Group d (n = 3)
Group d (n = 3)
Group e (n = 3)
Group e (n = 2)
Group e (n = 2)
Group f (n = 3)
Group f (n = 3)
Group f (n = 3)
Excluded (n = 6)
Not meeting inclusion criteria (n = 3)(i)





Allocated to intervention (n = 18)
(i) Received allocated intervention (n = 18)
(ii) Did not receive allocated intervention (n = 0)
Lost to follow-up (n = 1, asthma bronchiale∗)
Discontinued intervention (n = 0)
MU-WA-GI MU-GI-WA WA-GI-MU WA-MU-GI GI-MU-WA GI-WA-MU
Analyzed (n = 17)
Excluded from analysis (n = 1, asthma bronchiale∗)
Figure 1: CONSORT flow diagram (WA�water only condition, GI� ginger added to water, MU�mustard added to WA, ∗same
participant).
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blinding was judged as successful at t0. However, when
asked for the condition they received at the end of treatment
(t2), correct answers were given in 39 cases (76%) (MU:
n� 17, GI: n� 11, WA: n� 11).
3.7. Safety. A redness of the feet, which resolved within a few
minutes, was observed by the study nurse and participants
after all conditions. We detected no other adverse effects.
Based on our decision to discontinue the footbath
Table 1: Baseline (t0) characteristics of study’s participants.
Group (number) a (n� 3) b (n� 3) c (n� 3) d (n� 3) e (n� 2) f (n� 3)
Footbath sequence MU−WA−GI MU−GI−WA WA−GI−MU WA−MU−GI GI−MU−WA GI−WA−MU
Demographic
Age, years 21.00± 2.65 22.67± 2.08 23.00± 1.73 24.00± 3.61 19.50± 0.71 21.67± 1.15
BMI, kg/m2 22.87± 1.89 24.24± 8.43 21.06± 0.90 23.16± 4.40 23.90± 0.18 21.87± 1.15
Sex, female n (%) 2 (66.67) 2 (66.67) 2 (66.67) 2 (66.67) 1 (50.00) 2 (66.67)
Basler Befindlichkeit questionnaire (BBS)
Vitalitya 18.67± 3.39 19.33± 4.44 16.56± 5.20 17.33± 2.40 15.33± 5.89 19.67± 3.64
Intrapsychic balancea 22.33± 3.64 21.33± 3.50 22.67± 4.42 23.67± 1.41 22.50± 3.73 23.56± 3.32
Vigilancea 19.44± 3.13 18.11± 4.96 16.67± 3.20 19.78± 4.68 18.83± 7.19 19.33± 3.35
Social extroversiona 17.44± 4.39 15.89± 3.69 15.11± 3.37 20.00± 4.42 19.67± 3.50 17.00± 3.28
Total sum scoreb 77.89± 11.32 74.67± 10.46 71.00± 12.27 80.78± 8.94 76.33± 19.48 79.56± 10.96
Cardiorespiratory parameters
SDNN, ms 47.24± 10.87 49.06± 24.77 47.44± 9.94 52.33± 22.85 66.50± 19.14 46.43± 14.82
RMSSD, ms 24.42± 7.08 27.65± 15.46 29.18± 4.33 30.79± 16.58 47.85± 20.24 28.55± 10.16
LF/HF-ratio 7.03± 6.07 3.08± 1.98 4.23± 4.46 2.85± 1.11 2.21± 1.35 2.42± 1.75
Stress index, pts. 182.48± 91.74 234.78± 195.89 196.09± 90.90 181.18± 119.00 98.45± 57.35 176.30± 102.36
Respiration rate, 1/min 16.48± 2.08 18.90± 4.54 17.02± 1.23 14.48± 2.58 14.75± 2.22 19.35± 0.66
Notes: data are means± SD of all participants; if not, otherwise indicated. WA�water only condition, GI� ginger added to water, MU�mustard added to



















Figure 2: Subscale vitality of the Basler Befindlichkeit questionnaire (BBS) with means and 95% confidence intervals at t0, t1 and t2. Note:
WA�water only condition, GI� ginger added to water, MU�mustard added toWA, t0� baseline, t1� after immersion, and t2� follow-up.
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interventions when subjects felt uncomfortable or when they
reached the time maximum, no undesired skin reactions
(e.g., prolonged redness, irritation, or burning of the skin)
occurred.
4. Discussion
'e study findings demonstrated an increase in self-reported
vitality directly after footbaths with GI and MU, with the
highest increase after GI. After a 10-minute follow-up, all
three footbath conditions (including warm water only)
tended to induce autonomic changes with an increase in the
SDNN and a decrease in the stress index. Interestingly,
directly after the footbaths with GI, the SDNN initially
decreased, and the stress index slightly increased.
'ese results suggest an additional effect of footbaths
with GI or MU compared to footbaths with WA on self-
reported vitality, but a comparable effect on HRV. 'e
underlying mechanisms might be the skin penetration of the
active ingredients of GI and MU when externally applied
[23–25] and the binding to receptors of the transient re-
ceptor potential (TRP) ion channel superfamily [49–51].'e
active ingredients of ginger, shogaols, activate mainly
TRPV1 (TRP vanilloid 1) [49–51], which can be charac-
terized as heat receptors [50, 52, 53]. Allyl isothiocyanate, the
active ingredient of MU, in contrast, activates both TRPV1
and TRPA1 (TRP ankyrin 1) [49–51], with the latter being
classified as a cold receptor [50, 52, 53]. 'e differing re-
ceptor activation pattern might explain the different effects
of GI and MU on self-reported warmth perception as de-
scribed in a previous analysis [20]. 'e longer-lasting
warming effect of GI could be one possible explanation for
the more pronounced increase in self-reported vitality.
Interestingly, the ingestion of Korean red ginseng in the
treatment for cold sensitivity in the hands and feet has been
shown to significantly improve skin temperature but de-
creased self-reported vitality [54], so that warmth does not
seem to be the only determinant for vitality. Furthermore,
the physical effects of GI and MU might be not only at-
tributable to the warmth increase as TRPV1 receptors are
not only found in sensory neurons [49, 50, 52, 55], but also in
nonneuronal tissues including blood vessels [56]. Impor-
tantly, Doering et al. reported a significant reduction in the
cerebral blood flow velocity in the Arteria cerebri media after
mustard footbaths, which presumably was triggered by the
stimulation of thermoreceptors and the extracellular matrix
Table 2: Mean values for Basler Befindlichkeit questionnaire (BBS) at t0, t1, and t2 and between-substance differences as a function of time.
Mean± SD Mean difference (95% CI); |Cohen’s d|
WA MU GI ∆WA−MU ∆WA−GI ∆MU−GI
Vitalitya

































t0 19.76± 4.13 18.59± 4.61 17.71± 4.27 1.18 (−1.88; 4.24); 0.27 2.06 (−0.88; 4.99);0.49
0.88 (−2.22; 3.99);
0.20
t1 19.18± 3.41 19.47± 5.46 19.06± 3.80 −0.29 (−3.50; 2.91);0.06 0.12 (−2.41; 2.64); 0.03
0.41 (−2.89; 3.71);
0.09




































Notes: WA�water only condition, GI� ginger added to water, MU�mustard added to WA, t0� baseline, t1� after immersion, t2� follow-up,
CI� confidence intervals. a[4; 28]; b[16; 112].
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[23]. Michlig et al. examined the impact of the TRP channel
agonist capsaicin on the autonomic nervous system and
reported a stimulation of its sympathetic branch [57]. In-
terestingly, shogaols are reported to have similar effects like
capsaicin [58], the pungent component of chili peppers [51].
'e ingestion of both ingredients stimulates catecholamine
secretion [58, 59] from the adrenal medulla through beta-
adrenergic stimulation of the central nervous system
probably mediated by TRPV1 [51]. As MU mainly activates
different channels, no comparable effect on catecholamine
secretion could be observed in rats [51, 59]. 'e catechol-
amine secretion by GI supports the warming action [59] and
could explain the initial sympathetic response (lower SDNN,
higher stress index) directly after the footbaths. After the
short follow-up (10 minutes), however, the autonomic
balance shifted towards relaxation (higher SDNN, lower
stress index). Similarly, Saeki observed a delayed autonomic
change towards relaxation when adding the essential oil of
lavender to warm footbaths [14]. 'e comparable HRV-
changes in all three footbath conditions at the brief follow-
up may indicate that the effect on the autonomic nervous
system can be explained by the warmth of the water rather
than by the added substances.'e increase of the SDNN and
RMSSD indicates an overall strengthening of the para-
sympathetic nervous system and a reduction of the stress
level. A potential additional GI substance effect can be seen
in the indicated reduction of the LF/HF-Ratio. Yao et al.
reported a decrease of the ratio in a pleasant thermal en-
vironment by strengthening the vagal activity [60]. 'e
stronger influence of GI on the LF/HF-Ratio could therefore
be related to the higher influence on the heat balance
[20, 21]. 'e LF/HF-Ratio reflects the sympathovagal bal-
ance (with higher values indicating a dominance of the
sympathetic nervous system) [61]. However, due to its
complex nature, the LF/HF-Ratio should be interpreted with
caution [62]. In other studies, influences on the autonomic
activity [13, 63] and serum cortisol levels [16, 64] with in-
creases in relaxation have also been reported for footbaths.
Water temperature was not kept constant throughout the
footbath intervention, as in other studies [14, 16]. 'e mean
Table 3: Change in study’s outcome measures from t0 to t1 (∆t1− t0) and t0 to t2 (∆t2− t0) as a function of footbath condition.
∆t1− t0 ∆t2− t0
Diff 95% CI (L; H) |d| Diff 95% CI (L; H) |d|
Basler Befindlichkeit questionnaire (BBS)
Vitalitya WA 0.53 (−0.61; 1.67) 0.13 1.29 (−0.40; 2.99) 0.35
MU 1.59 (0.40; 2.78) 0.35 1.00 (−0.35; 2.35) 0.20
GI 2.82 (0.19; 5.45) 0.66 2.41 (−0.05; 4.87) 0.57
Intrapsychic balancea WA 0.53 (−0.86; 1.92) 0.14 0.00 (−1.37; 1.37) 0.00
MU 0.88 (−0.80; 2.57) 0.35 0.94 (−0.82; 2.70) 0.35
GI 0.12 (−1.51; 1.74) 0.04 0.00 (−2.30; 2.30) 0.00
Vigilancea WA −0.59 (−2.04; 0.87) 0.16 −1.06 (−2.83; 0.71) 0.27
MU 0.88 (−1.00; 2.76) 0.17 0.00 (−2.26; 2.26) 0.00
GI 1.35 (−1.50; 4.21) 0.33 0.35 (−2.42; 3.13) 0.08
Social extroversiona WA −0.29 (−1.97; 1.38) 0.06 −0.24 (−2.14; 1.67) 0.05
MU 0.24 (−1.33; 1.80) 0.07 −0.12 (−1.83; 1.60) 0.03
GI 0.71 (−1.06; 2.48) 0.18 0.82 (−0.84; 2.49) 0.22
Total sum scoreb WA 0.18 (−4.26; 4.62) 0.01 0.00 (−5.49; 5.49) 0.00
MU 3.65 (−0.53; 7.82) 0.30 1.88 (−3.48; 7.25) 0.15
GI 4.94 (−1.91; 11.79) 0.43 3.53 (−4.04; 11.10) 0.30
Cardiorespiratory parameters
SDNN, ms WA 1.82 (−6.02; 9.67) 0.09 9.08 (2.59; 15.56) 0.49
MU 4.40 (−5.64; 14.44) 0.29 8.33 (0.31; 16.36) 0.57
GI -3.79 (−10.71; 3.12) 0.23 11.75 (3.15; 20.34) 0.61
RMSSD, ms WA 0.82 (−3.93; 5.57) 0.06 3.92 (0.03; 7.81) 0.27
MU 1.68 (−4.25; 7.61) 0.14 3.75 (−1.70; 9.21) 0.29
GI 1.35 (−3.05; 5.75) 0.10 4.71 (−0.36; 9.78) 0.34
LF/HF-Ratio WA −0.11 (−1.49; 1.27) 0.05 0.03 (−1.08; 1.13) 0.01
MU −0.72 (−2.10; 0.66) 0.27 −0.34 (−2.33; 1.66) 0.12
GI −1.39 (−3.59; 0.81) 0.38 −1.24 (−3.33; 0.85) 0.33
Stress index, pts. WA −22.80 (−48.21; 2.60) 0.21 −61.60 (−106.30;-16.91) 0.66
MU −35.45 (-99.77; 28.86) 0.33 −61.55 (−112.53;-10.57) 0.66
GI 0.63 (−29.42; 30.67) 0.00 −43.23 (−91.05; 4.60) 0.42
Respiration rate, 1/min WA 0.56 (−0.57; 1.70) 0.18 −0.40 (−1.68; 0.88) 0.13
MU 0.59 (−0.36; 1.53) 0.23 0.59 (−0.63; 1.81) 0.24
GI 0.91 (−0.57; 2.39) 0.36 0.14 (−1.26; 1.53) 0.06
Notes: data are means± SD of all participants. WA�water only condition, GI� ginger added to water, MU�mustard added to WA, t0� baseline, t1� after
immersion, t2� follow-up, Diff�mean difference,CI� confidence intervals, L� lower confidence limit,H� upper confidence limit, d�Cohen’s d effect size).
a[4; 28]; b[16; 112]. Bold indicates confidence intervals that do not contain zero.
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temperature drop is expected to be approximately 1.6°C in
20 minutes for WA, GI, and MU [20], which means that the
water temperature was approximately 38.4°C at the end of
the experiment. Ishikawa conducted footbaths (40°C water
temperature, 15 minutes) in 110 healthy adults (20–39 years)
and observed a significant increase in SDNN (from 48± 19
to 60± 35ms), while no changes were seen for the RMSSD or
LF/HF-Ratio [30]. However, Uebaba et al. reported stress-
inducing effects and a parasympathetic suppression when
the water temperature reached 42°C [17]. 'us, autonomic
effects might derive primarily from participants’ experience
of comfort from the warm (but not too hot) footbaths rather
than from changes in skin temperature. In other words,
positive emotions originating from higher levels of the
central nervous system might trigger the observed shifts in
the autonomic balance [13]. 'is is in accordance with the
conclusion of Frank et al. who emphasized that skin surface
temperature mainly contributes to self-reported thermal
comfort and not to autonomic responses [65]. Furthermore,
the higher increase in self-reported vitality after GI and MU
may be related to the stronger stimulation (thermal and
chemical stimulation) compared to WA (only thermal
stimulation). 'e advantage of GI (higher and longer lasting
increase of self-reported vitality) over MU could be linked to
partial differing reaction pattern of the autonomic nervous
system after GI.'e primary sympathetic reaction induced a
counterregulation with a secondary parasympathetic dom-
inance.'us, stimulation and activation may induce feelings
of being vital and alive, in conjunction with perceptions of
also being relaxed.
Despite the randomized controlled study design, this
trial has several limitations. First, a potential limitation of the
study is the relatively small sample size. 'is was further
limited by the fact that three participants reported coffee
intake within three hours before the footbath intervention (1
in each condition). We decided to impute these measure-
ments as caffeine potentially affects self-reported vitality,
mental state, and HRV parameters. Second, we were able to
blind the participants at t0 by applying a room spray
containing essential oils; however, at t2, the majority named
the correct ingredient. 'is unblinding was probably trig-
gered by the substance-specific effects of GI and MU and
may have influenced the assessment of the self-reported
parameters at t2. In addition, the room spray may have had
an influence on the outcome measures of the study. In the
field of aromatherapy, essential oils are used to instill vitality
Table 4: Mean values for cardiorespiratory parameters at t0, t1, and t2 and between-substance differences as a function of time.
Mean± SD Mean difference (95% CI); |Cohen’s d|
WA MU GI ∆WA−MU ∆WA−GI ∆MU−GI
SDNN, ms

















































































Notes: WA�water only condition, GI� ginger added to water, MU�mustard added to WA, t0� baseline, t1� after immersion, t2� follow-up,
CI� confidence intervals.
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and to improve the perception of stress and the mea-
surable stress index [66]. Due to the small sample size, the
findings must be interpreted cautiously and do not allow
for a statement towards generalizability. 'at said, the
study does contribute to the greater understanding of
short-term self-reported vitality and how it can be in-
duced through GI andMU. Further studies are required to
confirm the observed effects, to examine the potential
therapeutic value of such thermogenic substances when
added to footbaths, and to clarify the potential modes of
action. Moreover, future studies should analyze the exact
powder compositions (e.g., with liquid chromatography-
tandem mass spectrometry for ginger [67] and time-of-
flight mass spectrometry for mustard products [68]) to
improve chemical standardization and to clarify the
specific effects of single components. Additional outcome
measures, such as the serum cortisol level, could aid in
gaining a better understanding of the physiological effects
of footbaths on vitality. 'ird, the study focused on
healthy young adult individuals. Clinical studies will be
important to conduct with patient-participants diagnosed
with primary physical or psychiatric disorder who suffer
from secondary fatigue to determine if footbaths could be
an appropriate treatment option to increase self-reported
vitality, improve the quality of life, and impact disease
etiology and pathogenesis. As part of such investigations,
the amount of thermogenic substance supplementation
and duration of such footbaths also merit further
investigation.
5. Conclusion
In conclusion, we were able to demonstrate a short-term
increase in self-reported vitality amongst healthy young
adult participants after warm footbaths. 'e effects differed
between footbaths with warm water only and footbaths that
were supplemented with ginger or mustard, with the highest
effects observed after ginger. 'e HRV data pointed to a
substance-independent autonomic change with a shift to an
increased parasympathetic activity at the brief follow-up. It
is possible that the heightened self-reported vitality induced
by such supplemented footbaths might contribute to a
higher quality of self-reported relaxation that is at once
characterized by vitality and relaxation. 'us, footbaths
could potentially serve as an accessible, natural, economical
therapeutic adjunct for those suffering from fatigue asso-
ciated with chronic illness by helping to induce states of
relaxation and to increase self-reported vitality when ther-
mogenic substances are added.
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